A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
about
Follow-up study of adolescents exposed to di(2-ethylhexyl) phthalate (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support.Levels of seven urinary phthalate metabolites in a human reference populationAbnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer Di(2-ethylhexyl) phthalate.Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkersThymic Stromal Lymphopoietin Neutralization Inhibits the Immune Adjuvant Effect of Di-(2-Ethylhexyl) Phthalate in Balb/c Mouse Asthma ModelActivation of PPARalpha and PPARgamma by environmental phthalate monoestersThe effects of phthalates on the ovaryMechanisms mediating environmental chemical-induced endocrine disruption in the adrenal glandCancer Risk Assessment in Welder's Under Different Exposure ScenariosAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadAcute Exposure to Di(2-Ethylhexyl) Phthalate in Adulthood Causes Adverse Reproductive Outcomes Later in Life and Accelerates Reproductive Aging in Female Mice.Molecular mechanisms mediating the effect of mono-(2-ethylhexyl) phthalate on hormone-stimulated steroidogenesis in MA-10 mouse tumor Leydig cellsAssessment of carcinogenicity of di(2-ethylhexyl)phthalate in a short-term assay using Xpa-/- and Xpa-/-/p53+/- mice.Integrating biomonitoring exposure data into the risk assessment process: phthalates [diethyl phthalate and di(2-ethylhexyl) phthalate] as a case study.Summary of dose-response modeling for developmental toxicity studies.Effects of diisononyl phthalate on atopic dermatitis in vivo and immunologic responses in vitro.Transcriptomic effects of di-(2-ethylhexyl)-phthalate in Syrian hamster embryo cells: an important role of early cytoskeleton disturbances in carcinogenesis?Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis.The toxicology of perfluorooctanoate.Di(2-ethylhexyl) phthalate inhibits antral follicle growth, induces atresia, and inhibits steroid hormone production in cultured mouse antral follicles.Phthalates and human healthEffect of a Large Dose of Di (2-ethylhexyl) phthalate (DEHP) on Hepatic Peroxisome in Cynomolgus Monkeys (Macaca Fascicularis).PPARalpha agonist-induced rodent tumors: modes of action and human relevance.The male reproductive system and its susceptibility to endocrine disrupting chemicals.Mono-(2-ethylhexyl) phthalate (MEHP) promotes invasion and migration of human testicular embryonal carcinoma cellsSpontaneous and drug-induced hepatic pathology of the laboratory beagle dog, the cynomolgus macaque and the marmoset.Mono(2-ethylhexyl) phthalate accelerates early folliculogenesis and inhibits steroidogenesis in cultured mouse whole ovaries and antral folliclesPhthalates in food and medical devices.PPARalpha- and DEHP-Induced CancersIn utero exposure to di-(2-ethylhexyl) phthalate decreases mineralocorticoid receptor expression in the adult testis.Effect of fibrate treatment on liver function tests in patients with the metabolic syndrome.Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk.Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation.Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalate.Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study.Genotoxicity of phthalates.Prenatal phthalate exposure: epigenetic changes leading to lifelong impact on steroid formation.New sampling device for on-site measurement of SVOC gas-phase concentration at the emitting material surface.
P2860
Q24533364-B8F360C0-D021-48CA-9058-E5DE783E078BQ24810842-24AD2F64-77AD-4D04-B7DF-BA0B177352AEQ24811734-7C9E619F-47C7-4AB6-8770-AE6E4BBAA57EQ24812167-D4436777-32CA-4A2D-8AE6-53CD7B6B7B8DQ24815263-96716E8C-E75B-4A0D-A70C-D29FE733BCE0Q27334146-609658FD-4EA5-4268-857D-65E5C1F1F25EQ28179002-71320BDE-251A-401B-8F2D-6E07ED78C531Q28387140-D9CC398B-4603-46A6-B845-481C6899C30DQ28389245-D09B59CB-20A3-421C-9078-6A08E211771AQ28395187-FB67482D-3A45-4EC0-989F-5F23E58FCCC9Q28397132-0D41F820-9FAA-4F87-8C54-D930C4DC0301Q30353940-449AA7C1-93FB-4770-8AC4-01E4AD997483Q30495487-44B57384-0A45-4FFE-AC57-3FC7C174A62DQ31048253-53E941FC-9F2A-4383-A0E2-D99123DA35AAQ31077492-AC1EE122-DFCA-47C9-9AC7-020E4DC28973Q33393656-C03704F7-6BB6-479B-88F5-A74F3C444AD9Q33789747-D4FB50E8-4E2F-4A6E-927F-5B781D173B7AQ34057399-67852381-73D9-4C8F-A931-9B444E8100DEQ34181630-039FCECE-C437-4B27-AA22-FEA3BF68C4A7Q34215080-FDFA12DF-17AB-46F5-B507-6AE3A5E21E78Q34343282-CAB89329-8871-47AE-B11E-2E3AC6D897ABQ35217745-191DBF1B-ABC7-4D3A-B99C-3983CC88AFC5Q35502266-904B1CBB-AE7D-46DD-9437-175C4F38FAD3Q35603991-7A3D26D9-8071-4DDF-9F6C-1516F569241AQ35631058-1EBD23A4-06F6-4346-89B6-658FA6E71E91Q35947297-9677E156-80C5-4E6B-BF37-BC23DE6B8721Q36000661-EEB6FA55-5FA7-4194-A726-7C4BF85080D2Q36086415-467D3187-C30C-4F56-9EBC-C2655DD7C44CQ36282771-CD418C39-49DA-4B68-A0FA-88AD60276958Q36548747-7A59B0A6-7AF6-46EA-A38D-C189A269FDA3Q36857053-81F778A4-4513-4C2C-A6C2-4065C873DA74Q37482962-BF5FB28C-4307-48E1-A1B2-093488AB1884Q37484551-7C9692BF-6445-4878-BFB3-CA0365978828Q37492574-2FC50F26-3A97-4275-BDDA-EDE71D8869A7Q37557621-6F8EE109-279C-4752-BA44-5B9401B597D6Q37916566-F8E6E3CD-72AB-48BD-8C16-F2A807EC6D9CQ38158164-013221D6-91CB-4373-8A93-A39032231328Q38244982-0A8698B6-F71F-4D0B-9C47-DAEB51846A69Q38797903-A5E3A429-2373-4178-B8D4-AF89C5DFC84DQ38921994-A0B07B82-48D4-48CE-9A19-C369DFE552EF
P2860
A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A cancer risk assessment of di ...... PA Risk Assessment Guidelines.
@ast
A cancer risk assessment of di ...... PA Risk Assessment Guidelines.
@en
type
label
A cancer risk assessment of di ...... PA Risk Assessment Guidelines.
@ast
A cancer risk assessment of di ...... PA Risk Assessment Guidelines.
@en
prefLabel
A cancer risk assessment of di ...... PA Risk Assessment Guidelines.
@ast
A cancer risk assessment of di ...... PA Risk Assessment Guidelines.
@en
P2093
P356
P1476
A cancer risk assessment of di ...... PA Risk Assessment Guidelines.
@en
P2093
Swenberg J
Wilkinson C
Williams G
van Gemert M
P304
P356
10.1006/RTPH.1999.1296
P407
P577
1999-06-01T00:00:00Z